Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

ECB. 2014; 3(11): 1075-1080


DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF STEROIDAL TETRAZOLES AS ANTIPROLIFERATIVE AND ANTIOXIDANT AGENTS

Shamsuzzaman, Mohd Asif, Abad Ali, Ashraf Mashrai, Hena Khanam, Asif Sherwani, Mohammad Owais.




Abstract

A series of steroidal tetrazole derivatives (7-9) has been obtained by facile and convenient method in a two-step process. All the newly
synthesized compounds were characterized by means of elemental analyses, IR, 1H NMR, 13C NMR and MS. The mean surface roughness
value (Ra) of compound 9 was found to be 10.32 measured with AFM. Lipinski’s ‘Rule of Five’ analysis and biological score predicted
higher intrinsic quality and revealed that these compounds possess good passive oral absorption. The antiproliferative activity was tested in
vitro against HeLa (cervical cancer), KCL-22 (myeloid leukemia), MDA-MBA-231 (breast cancer) and normal cell lines, blood peripheral
mononuclear (PBMC) by MTT assay. The synthesized compounds exhibited moderate to good activity against the three human cancer cell
lines and were found to be nontoxic to the normal cell lines. In addition, the synthesized compounds were tested for their in vitro
antioxidant activity by DPPH method in which compound 9 exhibited good antioxidant activity.

Key words: Tetrazoles, steroids, anti-tumour activity, antioxidants, DPPH






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.